A patient explanation package for osteoarthritis (PEP-OA)

• Research type

  Research Study

• Full title

  Explaining osteoarthritis: development and implementation of a multimedia Patient Explanation Package (PEP-OA)

• IRAS ID

  252365

• Contact name

  Clare Jinks

• Contact email

  c.jinks@keele.ac.uk

• Sponsor organisation

  Keele University

• Clinicaltrials.gov Identifier

  19/EE/0221, REC

• Duration of Study in the UK

  2 years, 3 months, 31 days

• Research summary

  Our aim is to improve osteoarthritis explanations for patients to:
  - help their understanding of their condition
  - make sense of the management approaches suggested to them

  Background: Osteoarthritis is common and can cause pain and mobility problems. All affected patients should be:
  - Given good information
  - Supported to self-manage their symptoms using exercise and weight loss (if needed)

  Osteoarthritis explanations from healthcare professionals often do not help patients to understand their condition. Because osteoarthritis can cause pain on moving joints, patients sometimes worry about doing exercise and question whether they can improve their symptoms. All patients need effective explanations to support them to understand why and how evidence-based care can improve their health.

  Approach: A Patient Explanation Package for OsteoArthritis (PEP-OA) will be developed. This will contain materials for patients and will be supported by a package of information for healthcare professionals to help them:
  - Use the explanation
  - Understand the importance of getting their explanations right.

  Methods: We will develop PEP-OA and the supporting package by:
  1) Developing and ranking the importance of osteoarthritis explanation statements to support patients in self-managing their condition
  2) Testing explanation statements to establish the impact of the statements ranked as being important
  3) Designing written and cartoon versions of a core explanation (relevant to all patients with osteoarthritis) and additional written statements (to tailor the core information to individual patients). Testing these with patients with osteoarthritis, lay people without osteoarthritis and healthcare professionals who diagnose osteoarthritis.
  Once tested, the feedback and learning will allow us to finalise PEP-OA.

  Learning about the interpretation and acceptability of explanation statements will inform the development of tools to support the use of the explanation package. Groups of experts and patients will support the development, testing and finalisation of the explanation package and supporting tools.

• REC name

  East of England - Cambridge East Research Ethics Committee

• REC reference

  19/EE/0221

• Date of REC Opinion

  22 Aug 2019

• REC opinion

  Further Information Favourable Opinion